Viewing Study NCT02174614



Ignite Creation Date: 2024-05-06 @ 2:58 AM
Last Modification Date: 2024-10-26 @ 11:26 AM
Study NCT ID: NCT02174614
Status: COMPLETED
Last Update Posted: 2020-10-14
First Post: 2014-06-23

Brief Title: The Effect of Cognitive Enhancement as a Precursor to Computer Based Training for Cognitive Behavioral Therapy CBT4CBT
Sponsor: Yale University
Organization: Yale University

Study Overview

Official Title: The Effect of Cognitive Enhancement as a Precursor to Computer Based Training for Cognitive Behavioral Therapy CBT4CBT
Status: COMPLETED
Status Verified Date: 2020-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Project 1
Brief Summary: The investigators are conducting a randomized clinical trial of rapid abstinence initiation and cognitive control training as a precursor to our new web-based version of the CBT4CBT Computer Based Training for Cognitive Behavioral Therapy program to evaluate its effectiveness relative to standard outpatient counseling at the Midwestern Connecticut Council of Alcoholism MCCA CCT will be used to assess attention working memory and inhibitory control and the computer-based training program CBT4CBT focuses on teaching basic coping skills presenting examples of effective use of coping skills in a number of realistic situations in video form and providing opportunities for patients to practice and review new skills while receiving cocaine abuse treatment
Detailed Description: 150 cocaine dependent individuals will be randomly assigned to one of 3 conditions delivered over 4 weeks in the context of intensive outpatient treatment 1 Treatment as Usual TAU 2 rapid abstinence initiation RAI or 3 computerized cognitive control training with escalating reinforcement for improved performance on training tasks CCT All participants will then receive an 8 week trial of CBT4CBT in addition to TAU Follow up evaluation thru 6 months posttreatment will assess durability and delayed emergence of treatment effects

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2P50DA009241-21 NIH None httpsreporternihgovquickSearch2P50DA009241-21